Success Metrics

Clinical Success Rate
88.9%

Based on 48 completed trials

Completion Rate
89%(48/54)
Active Trials
40(34%)
Results Posted
48%(23 trials)
Terminated
6(5%)

Phase Distribution

Ph phase_2
18
15%
Ph phase_3
13
11%
Ph not_applicable
79
68%
Ph early_phase_1
1
1%
Ph phase_1
4
3%
Ph phase_4
2
2%

Phase Distribution

5

Early Stage

18

Mid Stage

15

Late Stage

Phase Distribution117 total trials
Early Phase 1First-in-human
1(0.9%)
Phase 1Safety & dosage
4(3.4%)
Phase 2Efficacy & side effects
18(15.4%)
Phase 3Large-scale testing
13(11.1%)
Phase 4Post-market surveillance
2(1.7%)
N/ANon-phased studies
79(67.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

48 of 56 finished

Non-Completion Rate

14.3%

8 ended early

Currently Active

40

trials recruiting

Total Trials

117

all time

Status Distribution
Active(55)
Completed(48)
Terminated(8)
Other(6)

Detailed Status

Completed48
Recruiting31
Not yet recruiting14
Active, not recruiting9
Terminated6
unknown6

Development Timeline

Analytics

Development Status

Total Trials
117
Active
40
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.9%)
Phase 14 (3.4%)
Phase 218 (15.4%)
Phase 313 (11.1%)
Phase 42 (1.7%)
N/A79 (67.5%)

Trials by Status

terminated65%
active_not_recruiting98%
enrolling_by_invitation11%
not_yet_recruiting1412%
recruiting3126%
unknown65%
withdrawn22%
completed4841%

Recent Activity

Clinical Trials (117)

Showing 20 of 117 trialsScroll for more
NCT07052721Not Applicable

Randomized Study of an Analgesic Device Enabling Local Anesthetic Delivery and Neuromodulation After Shoulder/Foot Surgery

Completed
NCT03632044Phase 4

Evaluation of Trigeminal Nerve Blockade

Active Not Recruiting
NCT07215234Phase 1

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Recruiting
NCT06872125Phase 3

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

Recruiting
NCT06688578Not Applicable

Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait

Recruiting
NCT06887829Not Applicable

Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial

Recruiting
NCT04471168Not Applicable

Interest of Auriculotherapy in the Management of Chronic Insomnia

Completed
NCT05135091Phase 3

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

Recruiting
NCT06871124Not Applicable

Early Neuromodulation in Traumatic Brain Injury

Recruiting
NCT07622966Not Applicable

Effect of Osteopathic Manipulation on Circulating Immune Markers

Completed
NCT07608614Not Applicable

Sleep and Performance

Recruiting
NCT06996080Phase 3

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

Recruiting
NCT06990399Phase 3

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

Recruiting
NCT06874374Not Applicable

Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder

Active Not Recruiting
NCT06311162Not Applicable

Early Life Intervention in Pediatrics Supported by E-health - SMOKE

Recruiting
NCT04197765Not Applicable

acTBS Treatment for Inpatient Subjects With Suicidality

Active Not Recruiting
NCT04502563Not Applicable

LINK-HF2 - Remote Monitoring Analytics in Heart Failure

Completed
NCT07246473Not Applicable

Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage

Recruiting
NCT05887713Not Applicable

Novel Mental Health Therapies to Improve Military Readiness

Active Not Recruiting
NCT05992831Not Applicable

Transcranial Magnetic Stimulation for MCI

Recruiting

Drug Details

Intervention Type
DEVICE
Total Trials
117